These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34164818)

  • 1. Prostate-specific antigen testing of asymptomatic men in Australia: an observational study based on electronic general practice data.
    Franco GS; Hardie RA; Li L; Imai C; Sezgin G; Li J; McLeod A; Pearce C; Georgiou A
    Med J Aust; 2021 Sep; 215(5):228-229. PubMed ID: 34164818
    [No Abstract]   [Full Text] [Related]  

  • 2. US guideline may have led to drop in PSA testing among primary care physicians, studies find.
    McCarthy M
    BMJ; 2015 May; 350():h2906. PubMed ID: 26021822
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
    Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
    JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.
    Penson DF
    J Urol; 2013 Nov; 190(5):1766. PubMed ID: 24120783
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: variation among primary care physicians in prostate-specific antigen screening of older men.
    Penson DF
    J Urol; 2014 May; 191(5):1291-2. PubMed ID: 24745493
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation among primary care physicians in prostate-specific antigen screening of older men.
    Jaramillo E; Tan A; Yang L; Kuo YF; Goodwin JS
    JAMA; 2013 Oct; 310(15):1622-4. PubMed ID: 24129467
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer screening in New Zealand.
    Gray B
    N Z Med J; 2013 Sep; 126(1383):94. PubMed ID: 24157998
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen screening: An update of physician beliefs and practices.
    Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
    Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions.
    Shahangian S; Sharma KP; Fan L; Siegel DA
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1365. PubMed ID: 33934557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
    Moss S; Melia J; Sutton J; Mathews C; Kirby M
    Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
    Drummond FJ; Carsin AE; Sharp L; Comber H
    BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.
    Shahangian S; Fan L; Sharma KP; Siegel DA
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1352. PubMed ID: 33932150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
    Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
    Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.
    Van der Meer S; Löwik SA; Hirdes WH; Nijman RM; Van der Meer K; Hoekstra-Weebers JE; Blanker MH
    BMC Fam Pract; 2012 Oct; 13():100. PubMed ID: 23052017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms and PSA testing.
    Hudson B
    J Prim Health Care; 2012 Dec; 4(4):349-50; author reply 350. PubMed ID: 23205390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.